Section 460 IAC 14-5-6 - Informed consentAuthority: IC 12-8-8.5-4; IC 12-9-2-3; IC 12-9-5-1; IC 12-9-5-3
Affected: IC 12-9-5; IC 12-12-1; IC 16-39; IC 16-41-8-1
Sec. 6.
(a) An applicant's or eligible individual's informed consent must identify or describe:(1) the individual whose information is being requested;(2) the nature and scope of the information to be disclosed;(3) the person, agency, or other entity authorized to make the disclosure;(4) the person, agency, or other entity to which the disclosure is to be made;(5) if the request is for disclosure of information regarding alcohol or drug abuse diagnosis or treatment, mental illness, HIV, AIDS, or other infectious disease, a description of how the information is to be used; and(6) if the information to be disclosed is to be mailed, the address to which it is to be sent. An applicant or eligible individual may use the informed consent form provided by the VR program that complies with this section.
(b) If informed consent is being given for confidential information that includes a diagnosis or record of treatment involving any of the following, the informed consent must also comply with:(1) IC 16-39-2, IC 16-39-3, and IC 16-39-4 for mental illness.(2) IC 16-41-8-1 for HIV, AIDS, or other infectious disease.(3) 42 CFR, Part 2 for alcohol or drug abuse.(c) Informed consent remains valid until the date, event, or condition specified for its expiration unless otherwise revoked by the applicant or eligible individual. Filed 7/13/2015, 4:09 p.m.: 20150812-IR-460140507FRAReadopted filed 8/18/2021, 10:01 a.m.: 20210915-IR-460210198RFA